Idenix Pharmaceuticals (IDIX)
Idenix Pharmaceuticals Cash Flow
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Cash Flow - Operations | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Income | 11.45M | -18.12M | -11.71M | -13.91M | -8.236M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation, Depletion, Amortization | 0.819M | 1.163M | 0.948M | 1.04M | 1.048M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Non-Cash Items | 3.147M | 3.905M | 0.575M | 2.194M | -0.943M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Non-Cash Items | 3.966M | 5.068M | 1.523M | 3.234M | 0.105M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Deferred Income Taxes | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Changes in Assets/Liabilities | -32.67M | 0.07M | -3.404M | -2.612M | -6.761M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Operating Activities | -0.001M | 0.071M | 0.004M | 0.074M | 0.086M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Cash from Operating Activities | -17.26M | -12.92M | -13.59M | -13.21M | -14.81M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash Flow - Investing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Capital Expenditures | -0.371M | -0.085M | -0.332M | -0.226M | -0.194M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Acquisitions, Divestitures | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Investments | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Investing Activities | 0.411M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | ||||
| Cash Flow - Financing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Cash from Investing Activities | 0.04M | -0.085M | -0.332M | -0.226M | -0.194M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Debt Issued | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Equity Issued | 4.089M | 66.76M | 0.465M | 60.30M | 0.145M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Dividends Paid | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Financing Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Cash from Financing Activities | 4.089M | 66.76M | 0.465M | 60.30M | 0.145M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Foreign Exchange Effects | 0.113M | -0.177M | -0.207M | 0.085M | 0.147M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Change in Cash & Cash Equivalents | -13.01M | 53.58M | -13.66M | 46.95M | -14.71M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at beginning of period | 118.27M | 46.12M | 118.27M | 64.69M | 78.35M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at end of period | 105.26M | 118.27M | 64.69M | 78.35M | 31.41M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
